Clinical relevance of aberrant polypoid nodule scar after endoscopic submucosal dissection.
OBJECTIVE
To describe a series of patients with aberrant polypoid nodule scar developed after gastric endoscopic submucosal dissection (ESD), and to discuss its pathogenesis and clinical management.


METHODS
We reviewed retrospectively the endoscopic database of two academic institutions located in Brazil and Japan and searched for all patients that underwent ESD to manage gastric neoplasms from 2003 to 2015. The criteria for admission in the study were: (1) successful en bloc ESD procedure with R0 and curative resection confirmed histologically; (2) postoperative endoscopic examination with identification of a polypoid nodule scar (PNS) at ESD scar; (3) biopsies of the PNS with hyperplastic or regenerative tissue, reviewed by two independent experienced gastrointestinal pathologists, one from each Institution. Data were examined for patient demographics, Helicobacter pylori status, precise neoplastic lesion location in the stomach, tumor size, histopathological assessment of the ESD specimen, and postoperative information including medical management, endoscopic and histological findings, and clinical outcome.


RESULTS
A total of 14 patients (10 men/4 women) fulfilled the inclusion criteria and were enrolled in this study. One center contributed with 8 cases out of 60 patients (13.3%) from 2008 to 2015. The second center contributed with 6 cases (1.7%) out of 343 patients from 2003 to 2015. Postoperative endoscopic follow-up revealed similar findings in all patients: A protruded polypoid appearing nodule situated in the center of the ESD scar surrounded by convergence of folds. Biopsies samples were taken from PNS, and histological assessment revealed in all cases regenerative and hyperplastic tissue, without recurrent tumor or dysplasia. Primary neoplastic lesions were located in the antrum in 13 patients and in the angle in one patient. PNS did not develop in any patient after ESD undertaken for tumors located in the corpus, fundus or cardia. All patients have been followed systematically on an annual basis and no malignant recurrence in the ESD scar has been identified (mean follow-up period: 45 mo).


CONCLUSIONS
PNS may occur after ESD for antral lesions and endoscopically look concerning, especially for the patient or the family doctor. However, as long as curative R0 resection was successfully achieved and histology demonstrates only regenerative and hyperplastic tissue, PNS should be viewed as a benign alteration that does not require any type of intervention, other than endoscopic surveillance.
Vitor Arantes, Endoscopy Unit, Alfa Institute of Gastroenterology, School of Medicine, Federal University of Minas Gerais, Hospital Mater Dei Contorno, Belo Horizonte 30130-100, Brazil.
Vitor
V
Arantes
Vitor Arantes, Endoscopy Unit, Alfa Institute of Gastroenterology, School of Medicine, Federal University of Minas Gerais, Hospital Mater Dei Contorno, Belo Horizonte 30130-100, Brazil.
Noriya
N
Uedo
Vitor Arantes, Endoscopy Unit, Alfa Institute of Gastroenterology, School of Medicine, Federal University of Minas Gerais, Hospital Mater Dei Contorno, Belo Horizonte 30130-100, Brazil.
Moises Salgado
MS
Pedrosa
Vitor Arantes, Endoscopy Unit, Alfa Institute of Gastroenterology, School of Medicine, Federal University of Minas Gerais, Hospital Mater Dei Contorno, Belo Horizonte 30130-100, Brazil.
Yasuhiko
Y
Tomita
Early gastric cancer; Endoscopic submucosal dissection; Endoscopic treatment; Healing; Scar
Gastrointest Endosc. 1979 May;25(2):58-60
488651
Gastric Cancer. 2011 Jun;14(2):113-23
21573742
Br J Pharmacol. 2005 Jun;145(3):275-82
15778736
Endoscopy. 2015 Sep;47(9):829-54
26317585
Gastric Cancer. 2011 Jun;14(2):101-12
21573743
Am J Gastroenterol. 2007 Aug;102(8):1610-6
17403076
Gastrointest Endosc. 2013 Dec;78(6):946-52
23810327
J Med Invest. 2007 Feb;54(1-2):83-90
17380018
Rev Gastroenterol Mex. 2016 Jan-Mar;81(1):35-47
26552500
J Physiol Pharmacol. 2000 Dec;51(4 Pt 1):751-73
11192947
Dig Endosc. 2016 Jan;28(1):3-15
26234303
Kobe J Med Sci. 2001 Feb;47(1):35-45
11565193
J Clin Gastroenterol. 2010 Oct;44(9):615-9
20351567
Nat Rev Gastroenterol Hepatol. 2012 Sep;9(9):519-29
22664591